Christian Furlan Freguia PhD

Christian Furlan Freguia, PhD, has over 10 years of experience in the biotechnology sector with a successful track record in developing new drugs and translating programs to human clinical trials. In his previous role as Director of Research at Synthetic Biologics, Christian led the discovery and development activities of a novel oral biological drug, now in clinical trials. As part of this effort, he was responsible for GMP/GLP analytical development and GMP manufacturing.

Before Synthetic Biologics, Christian was a Director of Immunology at Imquest Biosciences, where he developed a new anti-HIV small molecule, now in the clinic, and novel cancer drugs, which resulted in several successful IND filings. Christian is the inventor of new technologies, some of which resulted in the founding of microbiome-based companies. Christian has authored more than 15 research and review articles, and he is an inventor on several patents. He holds a PhD in molecular biology and biochemistry from the University of Ferrara (Italy).